KAS
BLFS icon

Kemnay Advisory Services’s BioLife Solutions BLFS Stock Holding History

Kemnay Advisory Services’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,467
Closed -$35.5K – 1212
2025
Q4 		$35.5K Buy
+1,467
New +$38.4K 0.01% 388

Other funds holding BLFS

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Kemnay Advisory Services's BLFS Position: Q1 2026 in Review

Kemnay Advisory Services sold out of BioLife Solutions (BLFS) in Q1 2026, closing a stake of 1,467 shares — an estimated $35.5K sold.

Kemnay Advisory Services first reported a position in BLFS in Q4 2025 and held it in 1 quarter. The position peaked at $35.5K in Q4 2025. 187 funds tracked by Wall St. Rank hold BLFS as of Q1 2026.

  • Kemnay Advisory Services reported no remaining BioLife Solutions position as of Q1 2026 after selling out during the quarter.
  • Kemnay Advisory Services sold 1,467 BioLife Solutions shares in Q1 2026, an estimated $35.5K.
  • Kemnay Advisory Services first reported a position in BioLife Solutions in Q4 2025 and held it in 1 quarter.
  • Kemnay Advisory Services's BioLife Solutions position peaked at $35.5K in Q4 2025.
  • 187 funds tracked by Wall St. Rank held BioLife Solutions as of Q1 2026.

Based on Kemnay Advisory Services's 13F filing for Q1 2026, filed 15 May 2026.